Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05113628 |
Other study ID # |
Methylene blue |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
January 15, 2020 |
Est. completion date |
July 15, 2021 |
Study information
Verified date |
October 2021 |
Source |
Zagazig University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Thyroidectomy is the procedure by which surgeons treat various thyroid diseases and is
considered the commonest endocrinal surgery. Yet, it carries a risk for intraoperative
complications. The most distressing complications are recurrent laryngeal nerve and
parathyroid injuries. Methylene blue spray is a technique than can be used for easy
identification of both recurrent laryngeal nerve and parathyroid glands so we can avoid their
injuries.
Description:
Thyroid disorders constitute the second most common endocrine disease following diabetes
mellitus. Thyroid surgery is one of the most frequently operated Head and Neck surgeries.
Post-thyroidectomy complications are not uncommon. Parathyroids and Recurrent Laryngeal Nerve
(RLN) are two of the complications of thyroidectomy that cause significant postoperative
morbidity Due to the advances in thyroids surgeries, the occurrence of postoperative
complications has been decreased, but when occurred, they cause lifelong handicap. The most
important complications encountered are injury to the RLN and parathyroids. Meticulous
dissection is a key factor in minimizing the occurrence of complications During
thyroidectomy, careful dissection can protect the parathyroid glands and RLN. Various methods
were used including capsular dissection, attention to protection of the arterial supply to
parathyroids, avoiding unnecessary manipulation in the area of RLN Methylene blue spraying is
a new technique that allows identification of both parathyroid glands and recurrent laryngeal
nerves